Status:
COMPLETED
An Observational Study to Explore Clinical Characteristics of the Patients With T1 Non-small Cell Lung Cancer
Lead Sponsor:
Jiangsu Cancer Institute & Hospital
Conditions:
Non Small Cell Lung Cancer
Eligibility:
All Genders
Brief Summary
The real-world observational study was designed to explore the odd factors of lymph metastases in the patients with T1 non-small cell lung cancer, the effects of clinical characteristics on lymph meta...
Detailed Description
The trial is a multi-centre, real-world non-interventional observational study. In the study, the patients with T1 non-small cell lung cancer enrolled in clinics from 2015 to 2017 were included via a ...
Eligibility Criteria
Inclusion
- Patients who received surgeries from 2015 to 2017;
- Pathologically diagnosed patients with T1 non-small cell lung cancer;
Exclusion
- \- Patients with tumor treatments (including chemotherapies, radiotherapies, biological therapies, intervention therapies)
Key Trial Info
Start Date :
December 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 30 2018
Estimated Enrollment :
10885 Patients enrolled
Trial Details
Trial ID
NCT03413956
Start Date
December 1 2017
End Date
March 30 2018
Last Update
May 21 2018
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
China-Japan Friendship Hospital
Beijing, Beijing Municipality, China, 100029
2
China People's Liberation Army Hospital
Beijing, Beijing Municipality, China, 100853
3
Henan cancer hospital
Zhengzhou, Henan, China, 450003
4
Henan Cancer Hospital
Zhengzhou, Henan, China